Ali A Youssef Selected Research

Ali A Youssef Research Topics

Disease

17	Myocardial Infarction 03/2021 - 12/2006
6	Heart Failure 07/2012 - 05/2007
5	Cardiogenic Shock 03/2021 - 05/2007
5	Stroke (Strokes) 07/2010 - 06/2007
4	ST Elevation Myocardial Infarction 03/2021 - 05/2007
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 03/2008
3	Thrombosis (Thrombus) 07/2016 - 12/2007
3	Ischemic Stroke 07/2012 - 11/2007
3	Infarction (Infarctions) 07/2011 - 12/2007
2	Ventricular Tachycardia 03/2021 - 01/2021
2	Pulmonary Arterial Hypertension 05/2008 - 03/2008
2	Diabetes Mellitus 03/2008 - 03/2007
2	Body Weight (Weight, Body) 03/2008 - 03/2007
2	Pathologic Constriction (Stenosis) 09/2007 - 06/2007
1	COVID-19 03/2021
1	Ventricular Fibrillation 03/2021
1	Acute Coronary Syndrome 01/2021
1	Coronary Thrombosis 07/2016
1	Ischemia 07/2011
1	Coronary Stenosis (Coronary Artery Stenosis) 03/2008
1	Atherosclerosis 03/2008
1	Shock 01/2008
1	Spasm (Spasms) 01/2008
1	Coronary Artery Disease (Coronary Atherosclerosis) 11/2007
1	Hematoma 06/2007
1	Heart Block 01/2007
1	Inferior Wall Myocardial Infarction 01/2007
1	No-Reflow Phenomenon 12/2006
1	Unstable Angina 07/2006

Drug/Important Bio-Agent (IBA)

6	InterleukinsIBA 07/2011 - 05/2007
4	Losartan (Cozaar)FDA LinkGeneric 06/2009 - 03/2007
3	erucylphosphocholineIBA 10/2010 - 01/2008
3	omega-Chloroacetophenone (Mace)IBA 07/2010 - 05/2007
3	Interleukin-10 (Interleukin 10)IBA 01/2010 - 07/2007
2	CreatinineIBA 10/2010 - 11/2007
2	MonocrotalineIBA 05/2008 - 03/2008
2	Streptozocin (Streptozotocin)FDA Link 03/2008 - 03/2007
2	Connexin 43 (Connexin43)IBA 03/2008 - 03/2007
2	Simvastatin (Zocor)FDA LinkGeneric 03/2008 - 03/2007
2	Interleukin-18 (Interleukin 18)IBA 11/2007 - 05/2007
2	C-Reactive ProteinIBA 08/2007 - 07/2006
1	AmphetaminesIBA 07/2016
1	BenzodiazepinesIBA 07/2016
1	DiureticsIBA 07/2012
1	salicylhydroxamic acid (SHAM)IBA 07/2011
1	Messenger RNA (mRNA)IBA 07/2011
1	Interleukin-8 (Interleukin 8)IBA 07/2011
1	Endothelin-1 (Endothelin 1)IBA 07/2011
1	Matrix Metalloproteinases (MMPs)IBA 07/2011
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2011
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 07/2011
1	Caspase 3 (Caspase-3)IBA 07/2011
1	Tirofiban (Aggrastat)FDA Link 11/2009
1	Protein Kinase C-epsilonIBA 06/2009
1	p38 Mitogen-Activated Protein KinasesIBA 06/2009
1	Chemokine CXCL12IBA 06/2009
1	Cilostazol (Pletal)FDA LinkGeneric 05/2008
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2008
1	CD40 Ligand (CD40L)IBA 12/2007
1	CTLA-4 AntigenIBA 08/2007
1	PPAR gammaIBA 07/2007
1	MB Form Creatine KinaseIBA 05/2007
1	Nitroglycerin (Dynamite)FDA LinkGeneric 12/2006
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 12/2006
1	Atorvastatin (Lipitor)FDA Link 07/2006
1	von Willebrand FactorIBA 07/2006

Therapy/Procedure

12	Percutaneous Coronary Intervention 03/2021 - 12/2006
9	Therapeutics 03/2021 - 07/2006
3	Catheters 01/2008 - 12/2006
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 06/2007
2	Transplantation 07/2011 - 03/2008
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 01/2021
1	Stents 07/2010
1	Drug-Eluting Stents 07/2010
1	Cell- and Tissue-Based Therapy (Cell Therapy) 08/2008
1	Autologous Transplantation 03/2008